Pancreatic Cancer

From cancer-sniffing dogs to music therapy for pain, here’s what is making headlines in the cancer space this week.

Katie Couric lost both her husband and her sister to cancer within only a few years of one another. The legendary broadcast journalist spoke about the devastating loss of her loved ones and shared how she moved past her grief.

A practice improvement project at the Mayo Clinic helped to increase attention to family health history and identify those at risk for cancer.

The phase 3 POLO trial is the first randomized study to establish a biomarker-driven approach in the treatment of metastatic pancreatic cancer.

This essay nominating registered nurse Wendy Sconce for CURE®'s 2019 Extraordinary Healer® Award was written by Peggy Hufty of SSM Health Cancer Care, Lake St. Louis, Missouri.

In an interview with PEOPLE, "Jeopardy!" Host Alex Trebek reported he is in “near remission” from his stage 4 pancreatic cancer diagnosis.

The experimental oral anticancer regimen known as SM-88, which com­bines four drugs from different classes, shows promising efficacy and safety with no meaningful toxicity in patients with metastatic pancreatic cancer whose disease worsened despite previous treatment.

From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.

An expert sheds light on emerging combination treatments for pancreatic cancer.

Helping others is the last phase of recovery.

From artificial intelligence to a surprise FDA resignation, check out this week’s quick overview of what is making headlines in the cancer space.

We've got a sneak peek at what’s inside our Winter 2019 issue.

Alex Trebek, the long-time host of the popular game show "Jeopardy!", announced that he received a diagnosis of stage 4 pancreatic cancer.

Patients with pancreatic cancer face barriers to clinical trials as a standard of care.

A number of approved therapies can be used to treat pancreatic cancer, but many experts say that clinical trials offer patients greater hope.

Pancreatic cancer is one that strikes fear in the most stoic among us. Cancer.net tells us that although pancreatic cancer accounts for only 3% of cancer diagnoses in a given year, it is responsible for 7% of cancer deaths annually.

Adaptive clinical trials are poised to deliver hope to patients with pancreatic cancer.

SINGER ARETHA FRANKLIN, 76, died of advanced pancreatic cancer on Aug. 16 at her home in Detroit, with her family and friends at her bedside.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Pancreatic cancer is a silent killer in that symptoms usually start appearing after the cancer has advanced to a stage 3 or stage 2 level.

“Sometimes ‘a new normal’ seems to have a bad connotation,” said Nicole Lise Feingold, director of Patient Services at the Pancreatic Cancer Action Network (PanCAN).

After losing her husband and sister to cancer, journalist Katie Couric became an advocate for collaborative efforts to improve prevention and treatment.

Genetic testing is becoming more important in pancreatic cancer, especially since it can point toward more efficacious treatment regimens for some patients.

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.

“Disease control is key in our patients with locally advanced disease, as it may lead to opportunities for additional treatment interventions, including radiotherapy, or even, in some favorable cases, surgical resection,” said lead study author Pascal Hammel, M.D., Ph.D.

“There have been significant developments in our underpinnings for the development of pancreas cancer on both a molecular and genetic basis," said Eileen M. O'Reilly, M.D.